Neuromuscular

Latest News

June 18th 2018

California Startup Exploring Novel ALS Discovery Platform

A grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.

May 9th 2018

BHV-0223 Expanded Access Program Opened for ALS, as FDA Application Is Prepared

By Staff Writer

April 26th 2018

NP001 Fails to Meet Primary, Secondary Endpoints in ALS Trial

By Matt Hoffman

April 25th 2018

Ralph Kern, MD, MHSc: The State of Therapies for ALS

By Ralph Kern, MD, MHSc

March 16th 2018

FDA Approves Subcutaneous Immunoglobulin for CIDP

By Silas Inman

CME Content

Video

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Multimedia

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Video

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Video

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Video

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

Video

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Video

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Jessica Oswald, MD, MPH; Jeremy A. Adler, DMSc, PA-C; Amanda Nasser, MS, NP

Video

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA, FASCO; Girish Dhall, MD

Video

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

Video

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

Multimedia

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

Video

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Caring for Patients With ALS: A Brief Review

ByMiguel Chuquilin, MD,James Wymer, MD

February 21st 2018

Although there is no cure for ALS, there are treatments available that can improve the quality of life and prolong survival.

Neuropsychiatric Disorders and Amyotrophic Lateral Sclerosis

ByVeronica Hackethal, MD

February 7th 2018

What neuropsychiatric conditions are relatives of people with ALS at risk for? Are other genes involved besides C9orf72?

After Long Wait, Several Novel Therapies Are on the Horizon for ALS

ByStaff Writer

January 4th 2018

Two more novel therapies are quickly following the first approval in 2 decades for ALS.

Genetic Discovery in ALS

ByAnna B. Boyum, PhD

August 26th 2016

A genetic mutation suspected to be associated with amyotrophic lateral sclerosis risk has been confirmed through a large-scale research effort.

Tests for Autoantibodies in Brain Disease Raise Questions

BySamuel Pleasure, MD, PhD

October 2nd 2014

Serum testing for NMDAR and other autoantibodies is fraught with pitfalls, and careful clinical consideration is important.

Neuromuscular

Latest News

CME Content

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Caring for Patients With ALS: A Brief Review

Neuropsychiatric Disorders and Amyotrophic Lateral Sclerosis

After Long Wait, Several Novel Therapies Are on the Horizon for ALS

Genetic Discovery in ALS

Tests for Autoantibodies in Brain Disease Raise Questions

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup

FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis

Ractigen Completes Enrollment for RAG-17 in SOD1-ALS, Tanruprubart Shows Rapid Responses in GBS, Building a Multidisciplinary SMA Clinic

CN045 Promotes Oligodendrocyte Maturation, Modest Remyelination in Preclinical MS Study

Voyager to Advance 2 Tau-Targeted Alzheimer Therapies Toward Key Clinical Milestones